Effectiveness and safety of daily oral semaglutide in people with type 2 diabetes mellitus switching from sulfonylureas: a real-world retrospective study
Costa S, Miranda C, Elefante A, et al.
Diabetes Obes Metab. Pub. online 6 Mar 2025.
Leggi
Automated insulin delivery in elderly with type 1 diabetes: a prespecified analysis of the extension phase
Kudva YC, Henderson RJ, Kanapka LG, et al.
Diabetes Technol Ther. Pub. online 11 Mar 2025.
Leggi
An overview of obesity-related complications: the epidemiological evidence linking body weight and other markers of obesity to adverse health outcomes
Blüher M
Diabetes Obes Metab. Pub. online 11 Mar 2025.
Leggi
Time spent in glycaemic control with sustained body weight reduction with tirzepatide: a post hoc analysis of the SURPASS clinical trial programme
Bergman BK, Rosenstock J, Garvey WT, et al.
Diabetes Obes Metab. Pub. online 13 Mar 2025.
Leggi
Association of diet and waist-to-hip ratio with brain connectivity and memory in aging
Jensen DEA, Ebmeier KP, Akbaraly T, et al.
JAMA Netw Open. 2025;8(3):e250171.
Leggi
Association of BMI with mortality and health-related quality of life among 4.4 million adults: evidence from a nationwide, population-based, prospective cohort study
Wu Y, Lin C, Wang C, et al.
Diabetes Obes Metab. Pub. online 14 Mar 2025.
Leggi
Real-world use of tirzepatide among individuals without evidence of type 2 diabetes: results from the Veradigm® database
Hunter Gibble T, Chinthammit C, Ward JM, et al.
Diabetes Obes Metab. Pub. online 14 Mar 2025.
Leggi
Stati Generali sul Diabete 2025 – 19 marzo, CNEL Roma – Segui la diretta streaming
Gentili Soci, a un anno dagli Stati Generali 2024 il cammino prosegue con un appuntamento di grande rilevanza per mettere il diabete al centro dell’agenda politica e sanitaria. Domani, 19 marzo 2025, dalle ore 9:00 alle ore 17:00, si terranno gli Stati Generali sul Diabete 2025 presso il CNEL di Roma, un evento…
Leggi
Hematologic cancers among patients with type 2 diabetes prescribed GLP-1 receptor agonists
Ashruf OS, Hundal J, Mushtaq A, et al.
JAMA Netw Open. 2025;8(3):e250802.
Leggi
Continuous ranibizumab via port delivery system vs monthly ranibizumab for treatment of diabetic macular edema: the pagoda randomized clinical trial
Khanani AM, Campochiaro PA, Graff JM, et al.
JAMA Ophthalmol. 2025:e250006.
Leggi